LGT Fund Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-37,411
Closed -$2.79M 136
2022
Q2
$2.79M Buy
37,411
+25,931
+226% +$2.37M 0.41% 73
2022
Q1
$1.53M Buy
11,480
+9,480
+474% +$1.04M 0.2% 116
2021
Q4
$268K Buy
+2,000
New +$287K 0.08% 152

Other funds holding DXCM

LGT Fund Management's DXCM Position: Q3 2022 in Review

LGT Fund Management sold out of DexCom (DXCM) in Q3 2022, closing a stake of 37,411 shares — an estimated $2.79M sold.

LGT Fund Management first reported a position in DXCM in Q4 2021 and held it in 3 quarters. The position peaked at $2.79M in Q2 2022. 794 funds tracked by Wall St. Rank hold DXCM as of Q3 2022.

  • LGT Fund Management reported no remaining DexCom position as of Q3 2022 after selling out during the quarter.
  • LGT Fund Management sold 37,411 DexCom shares in Q3 2022, an estimated $2.79M.
  • LGT Fund Management first reported a position in DexCom in Q4 2021 and held it in 3 quarters.
  • LGT Fund Management's DexCom position peaked at $2.79M in Q2 2022.
  • 794 funds tracked by Wall St. Rank held DexCom as of Q3 2022.

Based on LGT Fund Management's 13F filing for Q3 2022, filed 19 Oct 2022.